Staging syndrome differentiation of diabetic retinopathy based on aqueous peptidomics
Phase 1
Not yet recruiting
- Conditions
- Diabetic retinopathy
- Registration Number
- ITMCTR2000003358
- Lead Sponsor
- Hunan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The surgical patients of ophthalmology in hospital mainly include cataract surgery and diabetic retinopathy surgery.
Exclusion Criteria
Malignant tumors and autoimmune diseases; secondary diabetes and gestational diabetes, hypertensive retinopathy, iris and ciliary body disease, glaucoma.
Study & Design
- Study Type
- Diagnostic test
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie aqueous peptidomic changes in diabetic retinopathy staging?
How does aqueous humor peptidomics compare to retinal imaging for diabetic retinopathy diagnosis?
Which specific peptidomic biomarkers correlate with diabetic retinopathy progression in clinical studies?
What adverse events are associated with aqueous humor-based diagnostic approaches for retinal diseases?
Are there combination therapies targeting VEGF and peptidomic markers for advanced diabetic retinopathy?